Skip to Main Content

Author Details

Nianxiang Zhang
2000
78
37
PMIDPaper TitleJournal TitlePublished Year
35199472Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015.Cancer Med2022
36274734The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition.Frontiers in Microbiology2022
35685648A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique.Frontiers in Pharmacology2022
35982398The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.BMC Cancer2022
34430717Factors associated with complex oral treatment device usage in patients with head and neck cancer.Clin Transl Radiat Oncol2021
34332039Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.Cancer Letters2021
33596096Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer.JCO Oncol Pract2021
33293428-Mediated Regulation of mA-Modified by mA Reader IGF2BP3 Drives ccRCC Progression.Cancer Research2021
34659550MIR-4507 Targets to Facilitate the Malignant Progression of Non-small-cell Lung Cancer.Journal of Cancer2021
30788162Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis.J Gastrointest Oncol2019
30876488How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.Gynecol Oncol2019
29140558Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.Cancer2018
31773031Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer.Int J Part Ther2018
30092967Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.JACC Cardiovasc Imaging2018
28185526Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.Leuk Lymphoma2017
28388292End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.J Clin Oncol2017
28270436Focal Adhesion Kinase as a Potential Target in AML and MDS.Mol Cancer Ther2017
27885271p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.Leukemia2017
26716915Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.Cancer2016
25248926Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.Clin Lymphoma Myeloma Leuk2015
25541150Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.Leukemia2015
25964256Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer.J Clin Oncol2015
25380958Development of a robust classifier for quality control of reverse-phase protein arrays.Bioinformatics2015
26058080Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.Cancer Cell2015
26073130Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.Cancer Cell2015
26674329Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients.BBA Clin2015
26711339MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199.Cell Rep2015
24858343The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.Biochim Biophys Acta2014
24248418Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.Digestive Diseases and Sciences2014
24414704Age-related epigenetic drift in the pathogenesis of MDS and AML.Genome Res2014
24868022Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.J Clin Oncol2014
23576428Transglutaminase 2 expression in acute myeloid leukemia: association with adhesion molecule expression and leukemic blast motility.Proteomics2013
22886728Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.Mol Imaging Biol2013
24223100Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.PLoS One2013
24149137Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.Oncologist2013
24127446Trastuzumab-related cardiotoxicity among older patients with breast cancer.J Clin Oncol2013
23564911Prognostic impact and targeting of CRM1 in acute myeloid leukemia.Blood2013
23634996Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.N Engl J Med2013
23257362Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.J Clin Invest2013
23583282Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.Am J Pathol2013
21653683Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.Annals of Oncology2012
22893484Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells.Ann Hematol2012
22645176Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.Blood2012
22581181SRMA: an R package for resequencing array data analysis.Bioinformatics2012
22415601Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.Cancer2012
22371383Anthracycline regimen adherence in older patients with early breast cancer.Oncologist2012
22311693Cancer prevention health services research: an emerging field.Journal of Cancer Education2012
23259068PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells.Leuk Res Treatment2012
21858090Mechanisms of resistance to decitabine in the myelodysplastic syndrome.PLoS One2011
21393379Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.Ann Oncol2011
  • 1 - 50 of 78

Recommended Authors

Collaborators

The University of Texas MD Anderson Cancer Center
Co-authored papers 24
Medical College of Georgia
Co-authored papers 20
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers 4
Georgia Cancer Center
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
University of Texas at San Antonio
Co-authored papers 3
MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
University of Texas Health Science Center at Houston Medical School
Co-authored papers 3
Columbia University
Co-authored papers 3
The University of Texas M. D. Anderson Cancer Center
Co-authored papers 3
MD Anderson Cancer Center
Co-authored papers 2
UTHealth School of Public Health
Co-authored papers 2
The Broad Institute of Harvard and MIT
Co-authored papers 2
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2